I am a healthcare professional

Notice


Welcome to MEDICALLY. This website is a non-promotional international resource intended to facilitate transparent scientific exchange regarding developments in medical research and disease management. It is intended for healthcare professionals outside the United Kingdom (UK) and Australia. The content on this website may include scientific information about experimental or investigational compounds, indications and services that are not approved or valid in your jurisdiction. Registration status and prescribing information of medicinal products may differ between countries. Roche and Genentech do not support, endorse or recommend the unapproved use of any compound or service in your jurisdiction, including those discussed on this website.


Please refer to local product information for any medicinal products mentioned. Information available on this website does not constitute professional medical advice, and Roche and Genentech accept no responsibility for access to or use of the same. Healthcare professionals outside the US are required to register and log-in to access the full range of content available on this website.


By clicking on one of the healthcare professional buttons below, you acknowledge you have read and understood this message and that you are requesting access to MEDICALLY. If you are not a healthcare professional, please use the other links below to access information relevant to you.


Cookies


We use cookies on this site to enable the site to function properly and to enhance your user experience. Cookies are files stored in your browser, which most websites use to personalize your web experience. Your information will only be used to provide information that is relevant to you. It will not be used for any other purpose. If you wish to restrict or block cookies, which are set on your device, then you can do this through your browser settings.


You can find out more about cookies by browsing our Privacy Policy.

 

I am a healthcare professional in Spain

Required field.

For healthcare professionals in Another Country browse medically.roche.com.

Not a healthcare professional? For individuals outside the US, browse Roche's patient website or roche.com. For individuals in the US, browse gene.com.

External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Neuroscience WMS 2024
Roche and Genentech at

WMS 2024

October 08 - October 12
Prague, Czechia
wms2024.com
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
12:30 PM
Duration 1hr Prague, Czechia
Retrospective assessment of feeding and nutrition after 2 years of risdiplam▼ treatment in children with Type 1 spinal muscular atrophy (SMA) using a novel scale
G Baranello, E Conway, Y Li, K Gorni
Neuroscience | Spinal Muscular Atrophy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 1hr Prague, Czechia
Assessing biomarkers of bone metabolism and the role of the IL-6 signalling pathway in patients with Duchenne Muscular Dystrophy
C De Ford, M Guridi, C Fruechtenicht, C Gee See, R Houghton, Y Chen, AP Murphy, C Wood, LM Ward, N Crabtree, EM. Mercuri, H McMillan
Neuroscience | Duchenne Muscular Dystrophy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 1hr Prague, Czechia
Natural history of bone health in Duchenne Muscular Dystrophy: A systematic review and implications for design of clinical trial
C De Ford, M Guridi, Y Chen, AP Murphy, C Wood, H McMillan, EM Mercuri, N Crabtree, LM Ward
Neuroscience | Duchenne Muscular Dystrophy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 1hr Prague, Czechia
A qualitative evaluation of meaningful change on the North Star Ambulatory Assessment and Performance of Upper Limb in Duchenne muscular dystrophy
AP Murphy, T Ciobanu, E Davies, A Gillman, L Barrett, A Johnson, J Mills, P Heinrich, K Przydzial, B Ewens, G Vandenberg, S Cano, A Mayhew
Neuroscience | Duchenne Muscular Dystrophy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 1hr Prague, Czechia
Investigating the data landscape of Duchenne Muscular Dystrophy: Answering your research questions with the right data source
H Furby, A Simpson, M Johnson, J Signorovitch,YMoride, G Castillon
Neuroscience | Duchenne Muscular Dystrophy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 1hr Prague, Czechia
Longitudinal evaluation of ambulatory function with ankle wearable technology in ambulant DMD
M Poleur, G Parinello, E Vrščaj, M Kumhera, C Bisson, K Aragon-Gawińska, C Anghelescu, A Daron, L Szabo, M Leanca, A Mirea, SKodsy, A Saleh, D Osredkar, J, A Potulska-Chromik, N Butoianu,D Eggenspieler2 P Strijbos and L Servais
Neuroscience | Duchenne Muscular Dystrophy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
03:15 PM
Duration 1hr Prague, Czechia
Cardiac MRI outcomes in patients with Duchenne muscular dystrophy treated with delandistrogene moxeparvovec: findings from EMBARK Part 1
G Walter, K Vandenborne, J Bourke, J Soslow, S Mason, E Palatinsky, C Wandel, W Zhang, C Reid, AP Murphy, M Manfrini, J Richardson, LR. Rodino- Klapac
Neuroscience | Duchenne Muscular Dystrophy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 1hr Prague, Czechia
Safety and efficacy of delandistrogene moxeparvovec versus placebo in Duchenne Muscular Dystrophy: Phase 3 EMBARK primary results
Mendell JR, Muntoni F, McDonald CM, Mercuri EM, Ciafaloni E, Komaki H, Leo-Astudillo C, Nascimento A, Proud C, Schara-Schmidt U, Veerapandiyan A, Zaidman CM, Guridi M, Murphy AP, Reid C, Wandel C, Asher DR, Darton E, Mason S, Potter RA, Singh T, Zhang W, Fontoura P, Elkins JS, Rodino-Klapac LR
Neuroscience | Duchenne Muscular Dystrophy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 1hr Prague, Czechia
Micro-dystrophin expression and safety with delandistrogene moxeparvovec gene therapy for DMD in a broad population: Phase 1b trial (ENDEAVOR)
C Proud, CM Zaidman, CM McDonald, JW Day,P Thrasher, DR Asher, AP Murphy, M Guridi, K Ding, C Reid, S Lewis, P Magistrado-Coxen, E Palatinsky, C Wandel, RA Potter, LR Rodino-Klapac, JR Mendell
Neuroscience | Duchenne Muscular Dystrophy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
12:15 PM
Duration 1hr Prague, Czechia
Demographic and clinical characteristics of risdiplam▼-treated and untreated adult patients with spinal muscular atrophy (SMA)
K Gorni, M Batech, CJ Guittari, A Carmona, SY Lee, A Poll, CS Sutherland, C Marini-Bettolo, MC Walter, M Jagut, J Haberlov, V Hodgkinson, E Yiu, LB Murphy, TREAT-NMD Global Data systems Oversight Committee (TGDOC), TREAT-NMD Global Registry Network for SMA, H Gordish-Dressman, A Simpson
Neuroscience | Spinal Muscular Atrophy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 1hr Prague, Czechia
Burden of illness for male patients with Duchenne muscular dystrophy (DMD) in a real-world setting, a Swedish registry study
H Furby, DM Boudreau, C De Ford, A-B Ekstrom, A-K Kroksmark, N Stelmaszuk, E Streja, J Wojtowicz, Q Yang6
Neuroscience | Duchenne Muscular Dystrophy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
01:45 PM
Duration 1hr Prague, Czechia
Real-world treatment with risdiplam▼ in adults with spinal muscular atrophy (SMA): US multicentre study
K Gorni, CJ Guittari, S Candrilli, LS Miles, A Simpson, S Shapouri
Neuroscience | Spinal Muscular Atrophy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 1hr Prague, Czechia
Fertility outcomes in risdiplam▼-treated male patients with spinal muscular atrophy: a multicenter case series
M Erdler, S Coskery, MR Frey, MA Lopez
Neuroscience | Spinal Muscular Atrophy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 1hr Prague, Czechia
Long-term safety and tolerability of delandistrogene moxeparvovec in Duchenne muscular dystrophy: phase 1 to phase 3 clinical trials
C Proud, CM McDonald, EM Mercuri, F Muntoni, CM Zaidman, S Dharia, S Mason, J Meng, AP Murphy, E Palatinsky, C Reid, C Wandel, JR Mendell
Neuroscience | Duchenne Muscular Dystrophy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
05:45 AM
Duration 15mins Congress Hall
Muscle MRI outcomes in patients with Duchenne Muscular Dystrophy treated with delandistrogene moxeparvovec: Findings from EMBARK Part 1
K Vandenborne, G Walter, V Straub, R Willcocks, S Forbes, S Ennamuri, W Zhang, C Reid, AP Murphy, M Manfrini, JS Elkins, LR Rodino-Klapac
Neuroscience | Duchenne Muscular Dystrophy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
06:30 AM
Duration 15mins Congress Hall
RAINBOWFISH: 2-year efficacy and safety data of risdiplam▼ in infants with presymptomatic SMA
L Servais, RS Finkel, MA Farrar, D Vlodavets, E Zanoteli, M Al-Muhaizea, APQC Araújo, L Nelson, B Jaber, K Gorni, H Kletzl, L Palfreeman, E Gaki, M Rabbia, D Summers, P Fontoura, E Bertini, on behalf of the RAINBOWFISH Study Group
Neuroscience | Spinal Muscular Atrophy

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.